Industry News
The latest news concerning companies involved in the development of treatments and therapies for diseases and conditions of the eye.
- A New Approach for Repairing/Rejuvenating Damaged Photoreceptors
- Gene Therapy in Ophthalmology Tables Updated
- DARPins Phase 2 Trial Results Fall Short
- The Top 10 Eyecare Technologies Developed in Israel
- Results of The AREDS2 HOME Study of Notal Vision’s Home Monitoring Device for AMD Announced
- Oxford BioMedica Gene Therapy Clinical Trials Resume
- New Gene Therapy Company, Spark Therapeutics, Launches
- Patient in ACTC Stem Cell Clinical Trial With Dry AMD Goes from Legally Blind (20/400) to Near Normal Vision (20/40)
- RetroSense Using Optogenetics to Treat Retinitis Pigmentosa and Dry AMD
- Hemera Biosciences Obtains Initial Funding for Gene-based Treatment for AMD
- DARPins, The Next “Game Changer” for Wet AMD?
- Bionic Eye for Treatment of Retinitis Pigmentosa Approved by FDA
- ThromboGenics Launches JETREA® in United States for Non-Surgical Treatment of Vitreomacular Adhesion
- Regeneron’s EYLEA® Injection Approved for the Treatment of Wet Age-Related Macular Degeneration in Europe
- Ohr Pharmaceutical Launches Clinical Trial to Evaluate Squalamine Eye Drops for Wet AMD
- Regeneron’s Eylea: A Game Changer for Treatment of Macular Degeneration?
- Early Positive Results in Ongoing Gene Therapy Trials for Wet AMD and Stargardt’s
- Patient Enrolled in Advanced Cell Technology’s Stem Cell Clinical Trial Shares Her Story
- Ocriplasmin Approved by FDA to Treat Vitreomacular Adhesion
- First Gene Therapy Approval on the Horizon: The Impact on Ophthalmology
- Healon EndoCoat Protective Gel for Cataract Surgery From Abbott Approved by FDA
- How Fovista Works to Increase Vision in the Treatment of Wet AMD: The Science Behind the Combined Therapy
- New Campaign to Build Consumer Awareness of Visian ICL as a Vision Correction Alternative to LASIK
- Second Patient With Stargardt’s Macular Dystrophy Treated With Stem Cells in Advanced Cell Technology Trial
- iStent from Glaukos Approved for Treatment of Glaucoma In Combination With Cataract Surgery
- Study Shows Fovista Administered in Combination With Lucentis Yields Better Results Treating Wet AMD Than Lucentis Alone
- Eye Drop to Treat Wet Macular Degeneration Granted Fast Track Designation by FDA
- Two-Year CATT Study of Results for Avastin vs. Lucentis in Treating Wet AMD
- Bausch + Lomb Acquiring ISTA Pharmaceuticals
- ACT Adds Third Clinical Trial Site for Testing Treatment of Dry Macular Degeneration With Embryonic Stem Cells
- Stem Cells Inc. Gets FDA Authorization to Initiate Clinical Trial to Use Human Neural Stem Cells to Treat Dry AMD
- Can Gene Therapy Help Treat Usher Syndrome Patients with Retinitis Pigmentosa?
- Do Femtosecond Lasers Improve Accuracy of Cataract Surgery?
- Will Macular Degeneration Eventually Be Treated With Eye Drops?
- Potential Major Breakthrough in Treatment of Wet Age-Related Macular Degeneration
- Visualization of Drusen and RPE With New Software Application for Zeiss HD-OCT: A New Aid for Assessing Both Dry and Wet AMD
- First Clinical Results of Using Embryonic Stem Cells to Treat Eye Disease Published in The Lancet
- Will 2012 be the Year for Gene Therapy in Ophthalmology?
- A Complete List of Current Ophthalmic Stem Cell Trials
- Bausch + Lomb Launches KeraSoft® IC Contact Lenses for Keratoconus and Other Irregular Corneas
- Progress Made in Treating Stargardt’s and Dry AMD Using Embryonic Stem Cells
- Who are the Top Ophthalmologists in America?
- New Gene Therapy Approach to Treating GA and Dry AMD
- Regeneron Announces FDA Approval of EYLEA™ (aflibercept) Injection for Wet Age-Related Macular Degeneration
- Six New Gene Therapy Projects Funded by Foundation Fighting Blindness
- Gene Therapy Trial for Retinitis Pigmentosa Based on Usher’s Syndrome To Begin
- ISTA Pharmaceuticals Announces Phase 3 Results for PROLENSA(TM) Eye Drops for Treatment of Pain and Inflammation After Cataract Surgery
- ISTA Pharmaceuticals Reports Results of Studies of REMURA(TM) Eye Drops for Dry Eye Disease
- ReLEx Femtosecond Laser System Represents Less Invasive Approach Than Standard LASIK Surgery
- Is BromSite More Effective Than Bromday Eye Drops For Postoperative Inflammation and Reduction of Ocular Pain?
- Is Non-Preserved Latanoprost Superior to Xalatan for Treatment of Glaucoma?
- ACT Expands Embryonic Stem Cell Treatment for Stargardt’s to UK
- VibeX™ Riboflavin/KXL™ System for the Treatment of Keratoconus Granted Orphan Drug Designation
- Drugs to Treat Both Leber Congenital Amaurosis and Retinitis Pigmentosa Fast Tracked by FDA
- Bausch + Lomb and Technolas™ Perfect Vision Introduce VICTUS™ Femtosecond Laser Platform
- Novogali Pharma Reports Positive Results in Phase II Study Comparing Treatment With Catioprost® vs. Travatan Z® in Glaucoma Patients
- Medicare to Reimburse for Implantable Miniature Telescope for End-Stage Macular Degeneration
- Canon Introduces New CR-2 Plus Digital Non-Mydriatic Retinal Camera Incorporating Fundus Auto-Fluorescence (FAF) Imaging
- Combining XIBROM(TM) and Lucentis May Provide Added Efficacy Over Lucentis Alone in Treating Neovascular Age-Related Macular Degeneration
- FDA Clears New Multicolor Pattern Scan Laser Photocoagulator from NIDEK
- Contaminated Repackaged Avastin Causes Severe Eye Infections and Blindness
- QLT Shows Positive 4 Week Efficacy in Phase II Study for Glaucoma Using Latanoprost Punctal Plug Delivery System
- Healon EndoCoat Protective Gel for Cataract Surgery Granted CE Mark by EU
- LipiFlow Treatment for Meibomian Gland Dysfunction Approved by FDA
- Using Stem Cells to Treat Dry AMD and Stargardt’s Macular Dystrophy
- A Potential Breakthrough in the Treatment of Glaucoma: Implant May Change Paradigm of Treatment
- Massachusetts Eye and Ear Infirmary and Schepens Eye Research Institute Join Forces
- Research Studies with Induced Pluripotent Stem Cells Suggest Opposite Results
- Quick Updates from ARVO 2011
- Avastin vs. Lucentis: The Origin of the Debate
- CATT Study Finds No Difference Between Avastin and Lucentis in Stopping Progression of Wet Macular Degeneration
- VEGF Trap-Eye Sees Positive Results in Phase 3 GALILEO Study in Patients with Macular Edema Due to CRVO
- Drug Eluting Device Slows Vision Loss in Geographic Atrophy Brought on by Dry AMD
- Merck Acquiring Inspire Pharmaceuticals
- FDA Approves Generic Version of Xalatan® Eye Drops for Glaucoma
- Latest News on Use of Femtosecond Lasers in Cataract Surgery
- Abbott Introduces Micro-Implantation Cataract Surgery Tools
- Lucentis Shown Effective in Treating Diabetic Macular Edema in Second Trial
- Bausch + Lomb to Distribute Technolas Femtosecond Laser System for Cataract and Refractive Surgery
- Omeros OMS302 Drug for Maintaining Pupil Dilation in Cataract Surgery Sees Positive Results in Clinical Trial
- Ellex to Introduce Ultrasound Mode for Eye Cubed Ocular Imaging System at ASCRS Meeting
- LensAR™ Laser System Receives FDA Clearance for Lens Fragmentation and Anterior Capsulotomy in Cataract Surgery
- Lucentis Approved in Europe to Treat Patients With Macular Edema Secondary to Retinal Vein Occlusion
- Opt-Align from Stereo Optical Helps Diagnose Computer Vision Syndrome and Prescribe Treatment
- FDA Approves New Cataract Multifocal Intraocular Lens From Abbott
- Technolas Growth Fueled by Only Comprehensive LASIK Treatment for Astigmatism Approved by the FDA
- ZYOPTIX® Advanced Nomogram From Technolas For Custom LASIK Eye Surgery Approved by FDA
- Argus™ II Retinal Prosthesis System for Treating Blindness from Retinal Disease Approved for Sale in Europe
- Should Optometrists Be Allowed to Perform Eye Surgery?
- Should Optometrists Be Allowed to Administer Injections to Eyelids?
- Positive News for Drug to Treat Leber Congenital Amaurosis and Retinitis Pigmentosa
- QLT Announces Phase II Clinical Trial Results for the Olopatadine Punctal Plug Delivery System
- 36-Month Study of Illuvien for Treatment of Diabetic Macular Edema Shows Positive Results
- Bausch and Lomb and Ista Drug Reps Only Ones Left Giving Samples
- Navilas Makes Retinal Laser Treatment a No-Brainer
- What is the Role of Nutrigenomics in Eye Health?
- Lutein, Zeaxanthin and Other Eye Health Supplements See Strong Market Growth
- California Medical Association Files Lawsuit to Block New Regulations Certifying Optometrists to Treat Glaucoma
- Advanced Cell Technology Obtains FDA Approval to Treat Dry AMD with Embryonic Stem Cells
- FDA Delays Approval of Iluvien to Treat Diabetic Macular Edema
- Is VEGF Trap-Eye Effective in Treating Macular Edema?
- Is New Laser Treatment for Glaucoma Safer Than Trabeculectomy?
- Alcon to Merge With Novartis
- Advanced Cell Technology Files Application for Trial to Treat Dry AMD With Human Embryonic Stem Cells
- Ocular Therapeutix Announces Successful Completion of Study of Sustained Drug Delivery Moxifloxacin Punctum Plug
- Topcon Launches New Multifocal Lens To Simultaneously Correct Presbyopia and Astigmatism
- FDA Approves Ozurdex for Treatment of Uveitis Affecting Posterior Segment of Eye
- Will the AdaptDx Device Assist With Early Detection of AMD?
- AstraZeneca to Develop Stem Cell Treatments
- What is the Future of Stem Cells in Treating Eye Disease?
- How Soon Will Iluvien be Available to Treat Diabetic Macular Edema?
- InSite Vision Commences Phase 1/2 Clinical Study of ISV-303 for Post-Surgical Ocular Pain and Swelling Following Cataract and Other Surgeries
- Is Iluvien From Alimera Sciences the Future of Ophthalmic Drug Delivery?
- Updated Clinical Results for Ellex 2RT Laser Therapy
- The Story Behind the Invention of Avastin and Lucentis
- Potential Breakthrough in Creating Artificial Retina from Human Embryonic Stem Cells
- On Demand Therapeutics Announces Novel Drug Delivery System for AMD
- The Notal Vision ForeseeHome Monitor for AMD
- The London Project To Cure Blindness – An Update
- Synchrony IOL Gives Almost 3D of Accomodation
- pSivida Announces Positive Results From The Two Phase 3 FAME™ Trials of Iluvien in Patients With Diabetic Macular Edema
- An Overview of New Treatments for Dry AMD
- Color-Changing Contact Lenses To Replace Blood Tests for Diabetics
- The First Ophthalmic Innovation Summit
- Oraya IRay In-office Stereotactic X-ray Treatment for AMD: A First Report
- NeoVista Rolls Out Novel Treatment for AMD Using Radiation
- CMS Reverses the Reimbursement for AVASTIN
- More AAO Highlights: Steroid implants for DME, Gene Therapy for Retinal Dystrophy, and More
- AAO Highlights: Lasers for Cataract Surgery, Laser Vision Correction Trends, and More
- Ellex Unveils New Diagnostic Ultrasound System at AAO
- Lux Biosciences’ Voclosporin Phase II/III Results Presented at AAO
- NeoVista®, Inc. Completes Enrollment in Pivotal CABERNET™ Study
- New Glasses Will Project Images Directly Onto the Retina
- CMS Reverses Position on Avastin for AMD
- Interesting News from the 2009 AAO Meeting from Ellex, NeoVista, Presbia and Others
- Aerie Pharmaceuticals’ AR-12286 Shows Positive Results in Glaucoma Patients in a Phase 2a Study
- Update on Avastin vs. Lucentis: CMS Ups the Ante
- Roche and Genentech Strike Deal With Surmodics For Biodegradable Microparticle Drug Delivery System for Lucentis
- Alimera Reports Results of Study of Iluvien for Diabetic Macular Edema
- Endo Optiks Introduces New High Resolution Endoscopes
- Can the Blood Vessels in Your Retina Predict Your Risk of Heart Disease?
- ThromboGenics Completes Patient Enrollment in Microplasmin Trial
- Alimera Sciences Announces Study of Iluvien® in Patients With Macular Edema Due to Retinal Vein Occlusion
- Zirgan™ for Herpes Keratitis from Sirion Therapeutics Approved by FDA
- ISTA Pharmaceuticals’ Bepreve™ Receives FDA Approval For Ocular Itching Associated With Allergic Conjunctivitis
- LenSx Obtains First Femtosecond Laser Approval for Capsulotomies
- Stemedica Applies for Patent Application for Diabetic Retinopathy Treatment
- Does Pseudo 2D Fractal Analysis Improve Detection of Retinal Disease?
- Will Electronic Contact Lens Make Bionic Vision a Reality?
- Can GS-101 Prevent Corneal Transplant Rejection?
- Abbott to Acquire Visiogen and Enlarge Ophthalmic Portfolio
- R-Tech Ueno Completes Enrollment in Phase 2 Clinical Study for the Agent UF-021
- ISTA Pharmaceuticals Announces Positive Results for Xibrom
- Resolvyx Announces Positive Data from Trial of Resolvin RX-10045 for Dry Eye
- Microneedle Patch Delivers Drugs to Eye Without Pain
- Aton Pharma Launches Extended Program for Preservative-Free Timoptic® in Ocudose®
- Sylentis to Start Clinical Trial of SYL040012 for the Treatment of Ocular Hypertension
- Gene Signal Announces Publication of Data on GS-101, Start of Phase III Study to Prevent Corneal Neovascularization
- Are TruFocals An Option for Presbyopia?
- NicOx Reacquires Rights to Glaucoma Drug From Pfizer
- SOLX Gold Shunt Cleared in Canada for Surgical Treatment of Glaucoma
- SENSIMED Triggerfish Electronic Contact Lens Continually Monitors Eye Pressure
- QLT Announces Interim Data for Phase 2 Punctal Plug Delivery System Clinical Trial
- Regeneron Commence Study of VEGF Trap-Eye for CVRO Treatment
- Acuvail™ From Allergan Receives FDA Approval for Post-Cataract Surgery Treatment
- PolyMedix Receives Patent for Compounds for Angiogenesis Inhibitors
- New EyeCon Eye Dropper Device From Japan Never Misses the Target
- OcuCure Therapeutics Eye Drop Shows Efficacy in Primates for AMD
- New Glaucoma Drug from Canadian Bio Med Systems and Ocular Therapeutics Pique Interest of Large Pharma Firms
- OXiGENE Announces Plans to Acquire Symphony ViDA Along With Rights to ZYBRESTAT™ for Ophthalmology
- Technolas Eyetracking Technology Approved For LASIK Surgery by FDA
- Alcon Starts Phase 2 Trial of NovaBay’s NVC-422 for Viral Conjunctivitis
- New Laser Treatment to Halt Blindness
- Lucentis Improves Vision in Retinal Vein Occlusions
- MatchedFlicker Software for Early Glaucoma Diagnosis Receives FDA Clearance
- Alcon Discontinues Development of Anecortave Acetate for Intraocular Pressure Reduction in Glaucoma Patients
- Stemedica Cell Technologies Announces Breakthrough Discovery in Use of Stem Cells for Treating Retinal Degeneration
- Bepreve™ Eye Drops from ISTA Obtain Approval of FDA Dermatologic and Ophthalmic Drugs Advisory Committee
- OXiGENE Starts ZYBRESTAT Phase 2 Study for Treatment of Polypoidal Choroidal Vasculopathy
- Inotek Pharmaceuticals Announces Positive Results for INO-8875 in Phase I/II Glaucoma Study
- RegeneRx Biopharmaceuticals, Inc. Plans Test of TB4 Eye Drops to Reduce Chemical Eye Damage
- Advanced Cell Technology, OHSU Researchers Show Safety, Efficacy of Human Embryonic Stem Cell (hESC)-Derived Retinal Pigment Epithelium (RPE)
- FDA Finds Bepreve Eye Drops from ISTA Effective At Treating Itching from Allergies, But Questions Data For Rejena Eye Drops for Treating Dry Eye
- Transcend Medical Raises $35 Million for Development of CyPass Glaucoma Treatment System
- EyeIC Raises Funds to Market MatchedFlicker Software for Glaucoma Diagnosis
- Allergan Announces FDA Approval for OZURDEX™ For Treatment of Macular Edema Following Branch Retinal Vein Occlusion or Central Retinal Vein Occlusion
- Can Femtosecond Lasers Be Used for Cataract Surgery?
- Future Applications of the Femtosecond Laser
- QLT Announces Positive Results from Visudyne-Lucentis Combination Therapy for Wet AMD
- Carl Zeiss Meditec Receives FDA Clearance for Cirrus HD-OCT Software Version 4.0
- Palomar Medical Technologies Secures OTC Clearance from FDA for Home Use Laser To Treat Eye Wrinkles
- Can Femtosecond Laser Be Used to Correct Myopia?
- Implantable Contact Lenses for Myopia
- FDA Approves Besifloxacin Drops for Treatment of Bacterial Conjunctivitis
- Summary of Surgical Techniques to Correct Presbyopia
- FDA Says LASIK Ads Must Warn Consumers of Side Effect Risks
- Bausch & Lomb Akreos® AO IOL Granted New Technology Intraocular Lens (NTIOL) Designation
- FDA Grants Accelerated Approval of Avastin for Brain Cancer (Glioblastoma) That Has Progressed Following Prior Therapy
- Visiogen Raises $40 Million to Support Global Commercialization of the Synchrony Dual Optic Accommodating Intraocular Lens
- IRIDEX Announces Shipment of New IQ 577(TM) Laser Systems
- B&L and 20/10 Perfect Vision form Technolas Perfect Vision
- Bayer and Regeneron Expand VEGF Trap-Eye to CRVO
- OptiMedica Corp. Presentations at ARVO 2009 to Cover PASCAL Laser Technology
- TransMolecular, Inc. Presentation at ARVO 2009
- Sirion Therapeutics Presentation at ARVO 2009
- ARVO 2009 Presentations – StemCells, Inc.
- Inotek Pharmaceuticals Presentations at ARVO 2009
- pSivida Corp Presentations at ARVO 2009
- Resolvyx Pharmaceuticals Presentations at ARVO 2009
- Santen and Merck Sign Licensing Agreement for Tafluprost Treatment for Glaucoma and Ocular Hypertension
- Othera Pharmaceuticals Announces Positive Interim Phase 2 Results of OT-551 Eye Drop Treatment for Dry AMD
- Ophthalmologists Opposing Legislation in at Least Five States Seeking to Expand Optometrists’ Scope of Practice
- Synchrony Accomodative Lens- Just One Diopter
- LensX Lasers Raises $22.36 Million for Cataract Laser
- Implantable Miniature Telescope for AMD From VisionCare Ophthalmic Technologies Secures Approval From FDA Ophthalmic Devices Advisory Panel
- Inlays, Onlays, Rings & Things
- Neurotech Reports NT-501 Substantially Slowed Loss of Vision in Subjects With Dry AMD Involving Geographic Atrophy
- NeoVista Raises $18 Million to Fund Continued Clinical Trials of Beta Radiation Therapy for Wet AMD
- Lux Biosciences Completes Patient Enrollment in LUCIDA Phase 3 Program for LUMITECT for Prevention of Corneal Transplant Rejection
- Advanced Cell Technology Ready to File Independent New Drug Application for Stem Cell Based Program for Treating Retinal Diseases
- Opko Health Terminates Late-Stage Trial Of Bevasiranib For Treatment Of Wet Age-Related Macular Degeneration
- Blind Man Fitted With Argus II Bionic Eye from Second Sight Now Sees Light
- Alcon AcrySof® IQ Toric IOL Approved for U.S. Patients with Cataracts and Astigmatism
- Pfizer Ophthalmics and Bausch & Lomb Announce Co-Promotion Agreement Covering Xalatan, Alrex, Lotemax and Zylet
- Diaton Tonometer For Measuring Intraocular Pressure Through Eyelid Approved by Mexico Ministry of Health
- Novagali Pharma Releases Data Pertaining to BAK-Free Eye Drops for Glaucoma Treatment
- Abbott Labs Completes Purchase of Producer of Advanced Refractive Technologies
- EyeScience Launches Comprehensive Online Resource Devoted to Age-Related Macular Degeneration Education and Prevention
- Aton Pharma Acquires Marketing Rights to Preservative-Free Timolol Product Line from Merck
- FDA Grants NeoVista’s Request to Utilize Novel Wet AMD Treatment in Compassionate Case
